Skip to main navigation Skip to search Skip to main content

Safety of eosinophil depletion

David J. Jackson, Ariel Munitz

Research output: Contribution to journalArticlepeer-review

Abstract

Since the first characterisation of the eosinophil, it has been associated with various allergic diseases as well as parasitic infections. The ability to manipulate eosinophils levels in mice has led to new perspectives regarding the roles of these cells in multiple diseases from asthma to cancer, as well as in health including metabolism and innate immunity. With the penetrance of potent eosinophil-depleting therapeutic agents it is important to scrutinise these potential roles as predicted from experimental mouse models alongside clinical observations from eosinophil-depleted patients. In this chapter, we comprehensively compare these data. Although no clinically important homeostatic role has been observed, so far, from eosinophil-depleted patients, the roles of eosinophils in health and disease require further study.

Original languageEnglish
Pages (from-to)238-252
Number of pages15
JournalERS Monograph
Volume2022
DOIs
StatePublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Safety of eosinophil depletion'. Together they form a unique fingerprint.

Cite this